As of 2024-12-13, the Fair Value of Intercept Pharmaceuticals Inc (ICPT) is -36.84 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 19.00 USD, the upside of Intercept Pharmaceuticals Inc is -293.90%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -309.20 | -344.70 | -274.90 | -91.43 | 221.82 | -159.68 |
| YoY growth | 14.21% | -11.48% | 20.25% | 66.74% | 342.62% | 86.47% |
| Market Cap (mil) | 794.39 |
| P/E | |
| Forward P/E |
| EPS | -1.47 |
| Avg earnings growth rate | 86.47% |
| TTM earnings | -61.61 |